Inflammatory skin diseases classified at molecular level

Inflammatory skin diseases classified at molecular level

In research published online April 15 in Science Immunology, distinct classes of human inflammatory skin disease are defined at the molecular level.

To examine the molecular dysregulation underlying inflammatory skin conditions, Yale Liu, M.D., from the Second Affiliated Hospital of Xi'an Jiaotong University in China, and colleagues single-cell-profiled CD45+ immune cell transcriptomes from skin samples of 31 patients: seven with , eight with psoriasis vulgaris, two with lichen planus, one with bullous pemphigoid, six with clinical/histopathologically indeterminate rashes, and seven healthy controls.

The researchers identified active proliferative expansion of the Treg and Trm components and universal T cell exhaustion in human rashes; antigen-presenting cells were attenuated. Skin-resident memory T cells demonstrated the greatest transcriptional dysregulation in both atopic dermatitis and psoriasis; recurrent abnormalities were also exhibited in the ILC and CD8+ cytotoxic lymphocytes in atopic dermatitis. Transcript signatures differentiating these rash types accurately identified disease class in untrained validation data sets. With these , clinicopathologically ambiguous rashes could be classified with diagnoses consistent with therapeutic response.

"By placing transcriptomic features of individual rashes in the context of a large, existing dataset, we seek a standardized framework to link molecular features to disease prognosis and drug response based on contributions from clinical centers worldwide," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further

What is that rash? Genetic fingerprints can help doctors diagnose and treat skin conditions more effectively

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Science Immunology

Copyright © 2022 HealthDay. All rights reserved.

Citation: Inflammatory skin diseases classified at molecular level (2022, April 18) retrieved 5 July 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors